• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋病奈瑟菌对莫匹罗星的敏感性,莫匹罗星是一种经过纳米脂质体改造的用于注射给药的抗生素。

Susceptibility of Neisseria gonorrhoeae Strains to Mupirocin, an Antibiotic Reformulated for Parenteral Administration in Nanoliposomes.

机构信息

Laboratory of Membrane and Liposome Research, Department of Biochemistry, IMRIC, The Hebrew University, Hadassah Medical School, Jerusalem, Israel

Department of Microbiology and Immunology, F. Edward Hèbert School of Medicine, Uniformed Services University, Bethesda, Maryland, USA.

出版信息

Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02377-17. Print 2018 Apr.

DOI:10.1128/AAC.02377-17
PMID:29339382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5913977/
Abstract

is an urgent antibiotic-resistant threat. This study determined the MICs of mupirocin to be 0.0039 to 0.0625 μg/ml for 94 strains. Cross-resistance with other antibiotics was not detected. Mupirocin, which is currently limited to topical administration, demonstrated activity by injection when delivered in nanoliposomes. The nanoliposomal formulation of mupirocin is a potential treatment for drug-resistant .

摘要

是一种紧迫的抗生素耐药威胁。本研究确定了 94 株菌对莫匹罗星的 MIC 为 0.0039 至 0.0625μg/ml。未检测到与其他抗生素的交叉耐药性。莫匹罗星目前仅限于局部给药,当以纳米脂质体形式给药时,显示出注射活性。莫匹罗星的纳米脂质体制剂是治疗耐药性的潜在方法。

相似文献

1
Susceptibility of Neisseria gonorrhoeae Strains to Mupirocin, an Antibiotic Reformulated for Parenteral Administration in Nanoliposomes.淋病奈瑟菌对莫匹罗星的敏感性,莫匹罗星是一种经过纳米脂质体改造的用于注射给药的抗生素。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02377-17. Print 2018 Apr.
2
Susceptibility to Closthioamide among Clinical and Reference Strains of Neisseria gonorrhoeae.淋病奈瑟菌临床株和参考株对氯硫酰胺的敏感性。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.00929-17. Print 2017 Oct.
3
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.淋病奈瑟菌抗菌药物敏感性监测 - 淋球菌分离株监测项目,美国 27 个监测点,2014 年。
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.
4
[Resistance of Neisseria gonorrhoeae to 4 antibiotics: an analysis of the situation in Guangzhou in 2002].[淋病奈瑟菌对4种抗生素的耐药性:2002年广州地区情况分析]
Di Yi Jun Yi Da Xue Xue Bao. 2003 Oct;23(10):1099-100.
5
Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria.可注射纳米莫匹罗星脂质体对多重耐药菌感染的治疗潜力
Pharmaceutics. 2021 Dec 17;13(12):2186. doi: 10.3390/pharmaceutics13122186.
6
Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.达累斯萨拉姆淋病奈瑟菌对抗菌药物的敏感性模式
East Afr Med J. 1999 Jun;76(6):330-4.
7
[Antimicrobal resistance of Neisseria gonorrhoeae strains in Hungary].[匈牙利淋病奈瑟菌菌株的抗菌耐药性]
Orv Hetil. 2015 Feb 8;156(6):226-9. doi: 10.1556/OH.2015.30079.
8
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.2011 - 2012年南京性传播疾病门诊有症状男性淋病奈瑟菌分离株的抗菌药物敏感性:对头孢曲松敏感性降低的分离株的遗传特征
BMC Infect Dis. 2014 Nov 27;14:622. doi: 10.1186/s12879-014-0622-0.
9
The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013.2012 - 2013年日本第二次全国男性尿道炎淋病奈瑟菌抗菌药物敏感性监测
J Infect Chemother. 2015 May;21(5):340-5. doi: 10.1016/j.jiac.2015.01.010. Epub 2015 Jan 31.
10
Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.印度淋病奈瑟菌抗菌药物敏感性模式的变化趋势以及头孢曲松敏感性降低的淋病奈瑟菌菌株的出现。
J Antimicrob Chemother. 2007 Sep;60(3):582-6. doi: 10.1093/jac/dkm238. Epub 2007 Jun 29.

引用本文的文献

1
New Insights into spp.-Produced Antibiotics: Genetic Regulation of Biosynthesis and Implementation in Biotechnology.关于 spp. 产生的抗生素的新见解:生物合成的基因调控及其在生物技术中的应用
Antibiotics (Basel). 2024 Jun 27;13(7):597. doi: 10.3390/antibiotics13070597.
2
Nano-mupirocin as tumor-targeted antibiotic: Physicochemical, immunotoxicological and pharmacokinetic characterization, and effect on gut microbiome.纳米莫匹罗星作为肿瘤靶向抗生素:物理化学、免疫毒理学和药代动力学特征以及对肠道微生物群的影响。
J Control Release. 2024 Sep;373:713-726. doi: 10.1016/j.jconrel.2024.07.045. Epub 2024 Aug 2.
3
Low Oxygen Concentration Reduces Susceptibility to Resazurin.低氧浓度降低了对刃天青的敏感性。
Antibiotics (Basel). 2024 Apr 26;13(5):395. doi: 10.3390/antibiotics13050395.
4
Formulation and Characterization of Mupirocin Nanomicelles in Insulin-Based Gel for Dermatological Application.用于皮肤科应用的基于胰岛素的凝胶中莫匹罗星纳米胶束的配方与表征
J Pharm Bioallied Sci. 2023 Jul;15(Suppl 2):S1178-S1181. doi: 10.4103/jpbs.jpbs_172_23. Epub 2023 Jul 11.
5
Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria.可注射纳米莫匹罗星脂质体对多重耐药菌感染的治疗潜力
Pharmaceutics. 2021 Dec 17;13(12):2186. doi: 10.3390/pharmaceutics13122186.
6
Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions.耐抗生素淋病奈瑟菌的流行病学、治疗方法和疫苗研发:当前策略和未来方向。
Drugs. 2021 Jul;81(10):1153-1169. doi: 10.1007/s40265-021-01530-0. Epub 2021 Jun 7.
7
Nanobiosystems for Antimicrobial Drug-Resistant Infections.用于抗微生物药物耐药性感染的纳米生物系统。
Nanomaterials (Basel). 2021 Apr 22;11(5):1075. doi: 10.3390/nano11051075.
8
Prospects of Nanostructure Materials and Their Composites as Antimicrobial Agents.纳米结构材料及其复合材料作为抗菌剂的前景
Front Microbiol. 2018 Mar 9;9:422. doi: 10.3389/fmicb.2018.00422. eCollection 2018.

本文引用的文献

1
Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action.淋病奈瑟菌的抗菌药物耐药性:全球监测及国际合作行动呼吁
PLoS Med. 2017 Jul 7;14(7):e1002344. doi: 10.1371/journal.pmed.1002344. eCollection 2017 Jul.
2
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting.基于系统评价和全球报告的2012年四种可治愈性传播感染的患病率和发病率全球估计
PLoS One. 2015 Dec 8;10(12):e0143304. doi: 10.1371/journal.pone.0143304. eCollection 2015.
3
Effect of solubilizing agents on mupirocin loading into and release from PEGylated nanoliposomes.增溶剂对莫匹罗星载入聚乙二醇化纳米脂质体及从其中释放的影响。
J Pharm Sci. 2014 Jul;103(7):2131-2138. doi: 10.1002/jps.24037. Epub 2014 Jun 4.
4
Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.日本的耐头孢曲松淋病奈瑟菌
Emerg Infect Dis. 2011 Jan;17(1):148-9. doi: 10.3201/eid1701.100397.
5
Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase.假单胞菌酸A与大肠杆菌B异亮氨酰-tRNA合成酶的相互作用。
Biochem J. 1980 Oct 1;191(1):209-19. doi: 10.1042/bj1910209.
6
Gonococcal pilin variants in experimental gonorrhea.实验性淋病中的淋菌菌毛蛋白变体
J Exp Med. 1987 May 1;165(5):1344-57. doi: 10.1084/jem.165.5.1344.
7
The clinical development of mupirocin.莫匹罗星的临床开发。
J Am Acad Dermatol. 1990 May;22(5 Pt 1):873-9. doi: 10.1016/0190-9622(90)70116-y.